The UK and Germany signal uncertainty after management communicated in mid-December that it will not...
At SEB's Nordic Seminar, CFO Larsen highlighted how management spent 2025 broadly derisking the equi...
* Acquisition of Volvo Construction Equipment dealer in Iowa * Adds 8% to PF'26e EBIT, 13x acquisiti...
Redeye provides an update on Biovica following the Q2 2025/2026 report, which showed weaker-than-exp...
Aneo has completed its recommended public cash offer and now controls approximately 92.
We expect Duell’s sales and adjusted EBITA to both decline y/y in Q1.
Redeye initiates coverage on Hacksaw, a fast-growing and highly profitable Remote Gaming Server (RGS...
Redeye comments on SSH Communications Security's profit warning issued today, where the company lowe...
* Market conditions remain challenging, lowering Q4e volumes * We lower '25e-'27e adj.
Redeye briefly comments on Alligator Bioscience announcing the outcome of its rights issue, with 64.
* Rights issue of SEK 51.8m to accelerate recycling expansion * Fully covered by subscription and un...
In a decision published today by the Swedish Competition Authority, we find that they have concluded...
Redeye comments on Litium’s announcement of a strategic partnership with Monitor ERP, where Litium b...
Redeye has changed lead analyst of Cheffelo and provides a preview ahead of the company’s Q4 report ...
Redeye notes that it now appears beyond all reasonable doubt that Novartis will not initiate any lit...
Redeye updates on Vitrolife after a site visit and a change of lead analyst.
Redeye leaves a comment following Alzinova’s announcement of a SEK50.
* Inks SEK 240m order with EU NATO customer (Ovzon-3 related) * 60% terminals, 40% SATCOM (6-month);...
Redeye is positive to GomSpace’s revised guidance, which confirms 2025 revenues and margins in the u...
